Home Industry Reports Custom Research Blogs About Us Contact us

Thyroid Ablation Devices Market Size & Share, By Product (Non-thermal, Thermal), Application (Cancer, Nodules), End-use (ASCs, Hospitals), Type, Regional Forecast, Industry Players, Growth Statistics Report 2023-2030

Report ID: FBI 1330


Published Date: Aug-2023


Format : PDF, Excel

Market Outlook:

Thyroid Ablation Devices Market size surpassed USD 146.77 Million in 2022 and is poised to reach USD 350.24 Million, growing at over 10.94% CAGR between 2023 and 2030. With a rising prevalence of thyroid diseases such as hyperthyroidism and thyroid cancer, the demand for thyroid ablation procedures is expected to increase. Additionally, technological advancements in ablation devices and growing awareness about the benefits of minimally invasive procedures are contributing to market growth.

Base Year Value (2022)

USD 146.77 Million

18-23 x.x %
24-33 x.x %

CAGR (2023-2030)


18-23 x.x %
24-33 x.x %

Forecast Year Value (2030)

USD 350.24 Million

18-23 x.x %
24-33 x.x %
Thyroid Ablation Devices Market

Historical Data Period


Thyroid Ablation Devices Market

Largest Region

North America

Thyroid Ablation Devices Market

Forecast Period


Get more details on this report -

Market Dynamics:

Growth Drivers & Opportunities:

1. Increasing prevalence of thyroid diseases: The growing incidence of thyroid disorders, including hyperthyroidism and thyroid cancer, is a major driver of the thyroid ablation devices market. Factors such as changing lifestyles, rising stress levels, and poor dietary habits are contributing to the rising prevalence of thyroid diseases worldwide.

2. Advancements in ablation technologies: Continuous advancements in thyroid ablation devices, including radiofrequency ablation (RFA) and laser ablation, are fueling market growth. These technologies offer precise and effective treatment options for thyroid nodules and thyroid cancer, driving their adoption among healthcare professionals.

3. Rising demand for minimally invasive procedures: Minimally invasive procedures are gaining popularity due to their numerous advantages over traditional surgical approaches. Thyroid ablation devices offer minimally invasive treatment options, resulting in reduced pain, shorter hospital stays, and quicker recovery times. The growing preference for minimally invasive procedures is expected to drive the market demand.

4. Increasing healthcare expenditure: Supportive healthcare policies, coupled with rising healthcare expenditure, are creating lucrative opportunities for the thyroid ablation devices market. Governments and private organizations are investing heavily in the healthcare sector, creating a conducive environment for market growth.

Report Scope

Report CoverageDetails
Segments CoveredType, Product, Application, End-Use, Region
Regions Covered• North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA)
Company ProfiledBoston Scientific Corp., BVM Medical System, Integra Life Sciences, Johnson & Johnson, Medtronic Plc., MedWaves, Olympus, StarMed Co.., Terumo Europe, Theraclion

Unlock insights tailored to your business with our bespoke market research solutions - Click to get your customized report now!


Industry Restraints & Challenges:

1. Lack of skilled healthcare professionals: The adoption of thyroid ablation devices requires skilled healthcare professionals who are proficient in using advanced technologies. However, there is a shortage of trained professionals in certain regions, hindering the growth of the market. Efforts to improve the training and education of healthcare professionals will be crucial for market expansion.

2. Stringent regulatory guidelines: The stringent regulatory guidelines for medical devices pose a challenge for market players. The approval and clearance processes for new thyroid ablation devices can be time-consuming and expensive, affecting market growth.

3. Patient safety concerns: While thyroid ablation procedures have shown promising results, there are still concerns regarding patient safety. Adverse events such as nerve damage or thyroid hormone imbalances may occur during these procedures, leading to reluctance among patients and healthcare professionals. Ensuring patient safety and addressing these concerns will be vital for market growth.

In conclusion, the global thyroid ablation devices market is expected to experience robust growth driven by factors such as the increasing prevalence of thyroid diseases, advancements in ablation technologies, rising demand for minimally invasive procedures, and increased healthcare expenditure. However, the market faces challenges in terms of the shortage of skilled healthcare professionals, stringent regulatory guidelines, and patient safety concerns. Overcoming these challenges and addressing market dynamics will pave the way for the growth and development of the thyroid ablation devices market.

Report Coverage & Deliverables

Historical Statistics Growth Forecasts Latest Trends & Innovations Market Segmentation Regional Opportunities Competitive Landscape
Thyroid Ablation Devices Market
Thyroid Ablation Devices Market

Regional Forecast:

The global Thyroid Ablation Devices Market is expected to witness significant growth across various regions, including North America, Asia Pacific, and Europe.

North America

North America is projected to dominate the market owing to the increasing prevalence of thyroid disorders, rising awareness among the population regarding available treatment options, and the presence of advanced healthcare infrastructure. Additionally, favorable reimbursement policies and a higher adoption rate of technologically advanced products further contribute to the region's market growth.

Asia Pacific

Asia Pacific is anticipated to witness rapid market growth due to the high prevalence of thyroid disorders, especially in countries like China and India. The increasing geriatric population, changing dietary patterns, and lifestyle-related factors are contributing to the rising incidence of thyroid diseases in the region. Furthermore, government initiatives to improve healthcare infrastructure, coupled with increasing healthcare expenditure, are expected to drive market growth in Asia Pacific.


Europe is expected to register substantial growth in the thyroid ablation devices market, primarily due to the increasing geriatric population and the high prevalence of thyroid disorders. The growing adoption of minimally invasive surgical procedures and the presence of well-established healthcare facilities in countries like Germany and the UK further support market growth in the region.

Get more details on this report -

Segmentation Analysis:

Segment: Product Type

Sub-Segment: Radiofrequency Ablation Devices

Radiofrequency ablation devices are one of the key sub-segments of the product type segment in the thyroid ablation devices market. These devices use heat generated through radiofrequency energy to destroy thyroid tissues that are either cancerous or causing dysfunction. They are minimally invasive and offer advantages such as targeted treatment, reduced risk of complications, and shorter recovery time. The increasing demand for minimally invasive procedures and the growing preference for radiofrequency ablation devices among healthcare professionals are driving the growth of this sub-segment in the market.

Get more details on this report -

Competitive Landscape:

The competitive landscape of the thyroid ablation devices market is highly fragmented, with several players competing for market share. Some of the key market players include:

1. Medtronic

2. Merit Medical Systems, Inc.

3. Esaote SpA

4. AngioDynamics, Inc.

5. HealthTronics, Inc.

6. Esaote Europe B.V.

7. Chongqing Haifu Medical Technology Co., Ltd.


9. Monteris Medical Inc.

10. The Cooper Companies Inc.

These companies are actively engaged in strategies such as mergers and acquisitions, collaborations, and product innovations to strengthen their market presence and gain a competitive edge. The market players are focusing on R&D activities to develop technologically advanced and more efficient thyroid ablation devices to cater to the increasing demand in the market.

Our Clients

Why Choose Us

Specialized Expertise: Our team comprises industry experts with a deep understanding of your market segment. We bring specialized knowledge and experience that ensures our research and consulting services are tailored to your unique needs.

Customized Solutions: We understand that every client is different. That's why we offer customized research and consulting solutions designed specifically to address your challenges and capitalize on opportunities within your industry.

Proven Results: With a track record of successful projects and satisfied clients, we have demonstrated our ability to deliver tangible results. Our case studies and testimonials speak to our effectiveness in helping clients achieve their goals.

Cutting-Edge Methodologies: We leverage the latest methodologies and technologies to gather insights and drive informed decision-making. Our innovative approach ensures that you stay ahead of the curve and gain a competitive edge in your market.

Client-Centric Approach: Your satisfaction is our top priority. We prioritize open communication, responsiveness, and transparency to ensure that we not only meet but exceed your expectations at every stage of the engagement.

Continuous Innovation: We are committed to continuous improvement and staying at the forefront of our industry. Through ongoing learning, professional development, and investment in new technologies, we ensure that our services are always evolving to meet your evolving needs.

Value for Money: Our competitive pricing and flexible engagement models ensure that you get maximum value for your investment. We are committed to delivering high-quality results that help you achieve a strong return on your investment.

Select Licence Type

Single User

US$ 4250

Multi User

US$ 5050

Corporate User

US$ 6150

Thyroid Ablation Devices Market Size & Share, By P...

RD Code : 24